Gencitabine and carboplatin as first-line therapy in advanced/metastatic NSCLC

被引：0
|
作者：
Savio, G. [1 ]
Laudani, A. [1 ]
Usset, A. [1 ]
Leonardi, V. [1 ]
Pepe, A. [1 ]
Palmisano, V. [1 ]
Agostara, B. [1 ]
机构：
[1] Hosp M Ascoli ARNAS CIVICO, Dept Oncol, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [21] Combination paclitaxel (Taxol(R))-carboplatin as first-line therapy for advanced ovarian cancer
    Meerpohl, HG
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 : 18 - 22
  • [22] Bevacizumab in der First-Line-Therapie des fortgeschrittenen NSCLCBevacizumab in the first-line therapy of advanced NSCLC
    Norbert Hasenöhrl
    [J]. Wiener Medizinische Wochenschrift, 2007, 157 (21-22) : 576 - 578
  • [23] Carboplatin/docetaxel as first-line therapy for gynecologic cancers
    不详
    [J]. ONCOLOGY-NEW YORK, 2001, 15 (06): : 807 - 808
  • [24] Pemetrexed-Carboplatin Plus Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC: KEYNOTE-021 Cohort G Update
    Borghaei, H.
    Langer, C.
    Gadgeel, S.
    Papadimitrakopoulou, V.
    Patnaik, A.
    Powell, S.
    Gentzler, R.
    Martins, R.
    Stevenson, J.
    Jalal, S.
    Panwalkar, A.
    Yang, J. C.
    Gubens, M.
    Sequist, L.
    Awad, M.
    Fiore, J.
    Saraf, S.
    Raftopoulos, H.
    Gandhi, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1791 - S1791
  • [25] First-line systemic real-world treatment of patients with advanced/metastatic NSCLC in the UK
    Wang, M.
    Dhokia, P.
    Menon, S.
    Martindale, B.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 22 - 22
  • [26] Evaluation of calculating carboplatin dosage in carboplatin-pemetrexed therapy as the first-line therapy for Chinese patients with advanced lung adenocarcinoma
    Zhu, Yixiang
    Xing, Puyuan
    Wang, Shouzheng
    Ma, Di
    Mu, Yuxin
    Li, Xue
    Xu, Ziyi
    Li, Junling
    [J]. THORACIC CANCER, 2018, 9 (03) : 400 - 407
  • [27] Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer
    Fountzilas, G
    Athanassiades, A
    Papadimitriou, V
    Dimopoulos, MA
    Bafaloukos, D
    Aravantinos, G
    Nicolaides, C
    Kalofonos, HR
    Papakostas, P
    Xiros, N
    Razi, E
    [J]. ONCOLOGY-NEW YORK, 1998, 12 (01): : 45 - 48
  • [28] Ipilimumab-nivolumab as first-line treatment in metastatic NSCLC
    El-Ghazzi, Nathan
    Lavaud, Pernelle
    [J]. BULLETIN DU CANCER, 2021, 108 (03) : 231 - 233
  • [29] Nivolumab plus ipilimumab for the first-line treatment of metastatic NSCLC
    Rijavec, Erika
    Indini, Alice
    Ghidini, Michele
    Tomasello, Gianluca
    Cattaneo, Monica
    Barbin, Francesca
    Grossi, Francesco
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (07) : 705 - 713
  • [30] New effective Therapy Option in the First-line NSCLC Therapy
    不详
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12)
12345